NSCLC and CRC are typically associated with mutations in KRAS, not NRAS48; in fact, the A549 cell line has a genotype of KRAS G12S and wild-type NRAS28, while HCT116 bears the KRAS G13D mutation and wild-type NRAS49. Here, KRAS is linked to colorectal carcinoma.